Bioinformatic analyses of human prostate cancer clinical datasets revealed that CAND1 mRNA level correlated with disease status, with higher expression correlated with metastatic prostate cancer and poorer patient survival. The gene discussed is CAND1; the disease is metastatic prostate carcinoma.